Year: 2023
Type: dissertation
Abstract: There are over 7,000 known rare diseases and over 80% have a simple Mendelian pattern of inheritance. Despite our knowledge of the genetic mutations that cause rare diseases, little is known of the cellular consequences of these genetic mutations. Functional studies on rare disease have fallen behind gene discovery since advances in genome sequencing have far outpaced the throughput in functional follow-up studies. To bridge the gap between genetic and functional information, I systematically phenotyped a human mutation open reading frame (hmORF) collection of 3,547 human coding variants using immunofluorescence and high-content automated confocal microscopy, and discovered 250 mislocalized variants, indicating that mislocalization plays an important role in Mendelian disease pathology. 53 unique mislocalization patterns were observed. The most common type of mislocalization was between organelles within the secretory pathway (59%). It is possible that many of the mislocalized secretory pathway variants fail to pass quality control in the ER and are retained and sorted for degradation. To support this hypothesis, I performed BioID on 16 ER-retained variants and discovered that all 16 variants associated more with ER quality control factors than their wild-type counterparts. To elucidate the degradation pathways of the ER-retained variants, I used immunofluorescence to measure protein abundance of each ER-retained variant after inhibition of the proteasome, autophagy, or VCP. I discovered that proteasome-dependent ERAD was the dominant degradation pathway for ER-retained variants. Finally, using luciferase reporter cells, I assessed the ability of the ER-retained variants to upregulate the IRE1 and ATF6 unfolded protein response pathways. I found that 35 variants could upregulate both the IRE1 and ATF6 pathways. In this study, I present the first large-scale, publicly available map of the impact of human variants on protein localization. Aside from serving as a resource for researchers interested in each variant, reference gene, or associated human disorder, the data answered fundamental questions about the frequency and characteristics of mislocalization events. Most notably, pathogenic variants are more commonly mislocalized than benign variants or variants of unknown significance. Mislocalizations within the secretory pathway and cytoskeleton are more common than others, which points towards the possibility of similar targets and or candidate compounds being useful to correct an entire class of mislocalizations and therefore potentially an entire class of disorders.
Source: TSpace (University of Toronto)
Author: Lacoste, Jessica Sachiko Chantal
Institution: University of Toronto
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7133034773
